Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How artificial intelligence might disrupt diagnostics in hematology in the near future. | Oncogene | 2021 | 34103684 | PubTator, text mining | PubMed |
| The Role of Vitamin D in Adipose Tissue Biology: Adipocyte Differentiation, Energy Metabolism, and Inflammation. | J Lipid Atheroscler | 2021 | 34095008 | PubTator, text mining | PubMed |
| Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia. | Front Oncol | 2021 | 34094982 | PubTator, text mining | PubMed |
| Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma. | Front Oncol | 2021 | 34094917 | PubTator, text mining | PubMed |
| Whole genome, exon mutation and transcriptomic profiling of acute myeloid leukemia: A case report. | Oncol Lett | 2021 | 34084226 | PubTator, text mining | PubMed |
Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients. | Transplant Cell Ther | 2021 | 34082159 | PubTator, text mining | PubMed |
| MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF. | Cell Death Differ | 2021 | 34079078 | PubTator, text mining | PubMed |
| Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia. | Aging (Albany NY) | 2021 | 34074803 | PubTator, text mining | PubMed |
| Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by NPM1 Mutation. | Diagnostics (Basel) | 2021 | 34072516 | PubTator, text mining | PubMed |
| Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor. | Cancers (Basel) | 2021 | 34071607 | PubTator, text mining | PubMed |
| Chromosomal Instability in Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | 34071283 | PubTator, text mining | PubMed |
| The Ribosomal Gene Loci-The Power behind the Throne. | Genes (Basel) | 2021 | 34069807 | PubTator, text mining | PubMed |
| Etiology of Acute Leukemia: A Review. | Cancers (Basel) | 2021 | 34066700 | PubTator, text mining | PubMed |
| Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions. | Viruses | 2021 | 34066091 | PubTator, text mining | PubMed |
| Metabolic Disturbances in Rat Sublines with Constitutionally Altered Serotonin Homeostasis. | Int J Mol Sci | 2021 | 34065591 | PubTator, text mining | PubMed |
| Transient Receptor Potential (TRP) Channels in Haematological Malignancies: An Update. | Biomolecules | 2021 | 34065398 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches. | Cancers (Basel) | 2021 | 34065376 | PubTator, text mining | PubMed |
| The Impact of Epigenetic Modifications in Myeloid Malignancies. | Int J Mol Sci | 2021 | 34065087 | PubTator, text mining | PubMed |
| Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation. | Pharmaceuticals (Basel) | 2021 | 34063204 | PubTator, text mining | PubMed |
| Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. | Bone Marrow Transplant | 2021 | 34059800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=59